AmyLeeLightnerMD

Colon & Rectal Surgery • Cleveland, OH

Physician

Join to view full profile

Dr. Lightner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lightner's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 216-870-6998
Is this information wrong?

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2008 - 2015
Mayo Clinic College of Medicine and Science (Rochester)Residency, Colon and Rectal Surgery, 2008 - 2009
Boston University School of MedicineClass of 2008

Certifications & Licensure

CA State Medical License 2023 - 2025
OH State Medical License 2016 - 2024
MN State Medical License 2015 - 2019
American Board of Colon and Rectal Surgery Colon & Rectal Surgery
American Board of Surgery Surgery

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

Stem Cell Coated Fistula Plug in Patients With Crohn's RVF Start of enrollment: 2017 Oct 19
Completed
Phase 1
Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's Start of enrollment: 2021 Jun 01
Withdrawn
Phase 1
Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease Start of enrollment: 2020 Nov 19
Recruiting
Phase 1, Phase 2
Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease Start of enrollment: 2020 Oct 28
Recruiting
Phase 1, Phase 2
Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease Start of enrollment: 2020 Oct 28
Recruiting
Phase 1, Phase 2
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC) Start of enrollment: 2020 Nov 10
Recruiting
Phase 1, Phase 2
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis Start of enrollment: 2020 Nov 04
Recruiting
Phase 1, Phase 2
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES) Start of enrollment: 2020 Jul 28
Recruiting
Not Applicable
Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease Start of enrollment: 2021 Apr 01
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

22 citations
Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?
Amy L. Lightner, Nicholas P. McKenna, Ahmad Alsughayer, William S. Harmsen, Kekoa Taparra
Diseases of the Colon and Rectum. 2019-11-01
15 citations
Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study.
Jeong Yeon Kim, Karen Zaghiyan, Amy L. Lightner, Phillip Fleshner
BMC Surgery. 2020-03-05
29 citations
The Role of Temporary Fecal Diversion.
Amy L. Lightner, John H. Pemberton
Clinics in Colon and Rectal Surgery. 2017-05-22

Press Mentions

CORRECTING and REPLACING Direct Biologics Reports Compelling Data as ExoFlo™ Expanded Access Program in Hospitalized COVID-19 Patients with Moderate-to-Severe ARDS Surpasses 100 SubjectsApril 19th, 2023
Direct Biologics Reports Compelling Data as ExoFlo™ Expanded Access Program in Hospitalized COVID-19 Patients with Moderate-to-Severe ARDS Surpasses 100 SubjectsApril 19th, 2023
Direct Biologics Reports Compelling Results from Phase 2 Trial with ExoFlo™ in Hospitalized Patients with Respiratory Failure or Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19March 14th, 2023
Join now to see all

Professional Memberships

American College of Surgeons - ACS
Member

Hospital Affiliations

Cleveland ClinicCleveland, Ohio
Scripps Green HospitalLa Jolla, California